Chlorhexidine in preterm babies
Use of chlorhexidine as a topical antiseptic for the prevention of nosocomial sepsis in premature neonates < 29 weeks: a blinded randomised controlled trial
Sandie Bredemeyer
169 participants
Apr 4, 2005
Interventional
Conditions
Summary
Strategies for reducing infection are vital in caring for the premature neonate, and include, the use of a topical antiseptic for skin cleansing prior to any invasive procedure that compromises the skin barrier. There is currently little research addressing the issue of what antiseptic solution is best and safest for use in this vulnerable neonatal population. Consequently a wide range of solutions are utilised within the NICU setting
Eligibility
Inclusion Criteria1
- Inborn infants < 29 weeks. Informed parental consent.
Exclusion Criteria1
- Parental consent not given. Ex utero transfer, unlikely to survive major congenital anomaly.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Aqueous chlorhexidine 0.5% (intervention group) applied topically. The solution is applied prior to each invasive procedure for both control and intervention groups.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000050459